Neurotoxic agents -- Health aspects -- Evaluation : Adequacy of the comprehensive clinical evaluation program : nerve agents / Committee on the Evaluation of the Department of Defense, comprehensive Clinical Evaluation Program, Division of Health Promotion and Disease Prevention, Institute of Medicine
Neurologic disorders caused by exposure to toxic substances through ingestion, injection, cutaneous application, or other method. This includes conditions caused by biologic, chemical, and pharmaceutical agents
Neurologic disorders caused by exposure to toxic substances through ingestion, injection, cutaneous application, or other method. This includes conditions caused by biologic, chemical, and pharmaceutical agents
Neurologic disorders caused by exposure to toxic substances through ingestion, injection, cutaneous application, or other method. This includes conditions caused by biologic, chemical, and pharmaceutical agents
Disorders associated with acute or chronic exposure to compounds containing ARSENIC (ARSENICALS) which may be fatal. Acute oral ingestion is associated with gastrointestinal symptoms and an encephalopathy which may manifest as SEIZURES, mental status changes, and COMA. Chronic exposure is associated with mucosal irritation, desquamating rash, myalgias, peripheral neuropathy, and white transverse (Mees) lines in the fingernails. (Adams et al., Principles of Neurology, 6th ed, p1212)
Disorders associated with acute or chronic exposure to compounds containing ARSENIC (ARSENICALS) which may be fatal. Acute oral ingestion is associated with gastrointestinal symptoms and an encephalopathy which may manifest as SEIZURES, mental status changes, and COMA. Chronic exposure is associated with mucosal irritation, desquamating rash, myalgias, peripheral neuropathy, and white transverse (Mees) lines in the fingernails. (Adams et al., Principles of Neurology, 6th ed, p1212)
1
Neurotoxicity Syndromes -- diagnosis : Fundamental neuropathology for pathologists and toxicologists : principles and techniques / [edited] by Brad Bolon, Mark T. Butt
Neurotoxikologie : Environmental neurotoxicology / Committee on Neurotoxicology and Models for Assessing Risk, Board on Environmental Studies and Toxicology, Commission on Life Sciences, National Research Council
Neurologic disorders caused by exposure to toxic substances through ingestion, injection, cutaneous application, or other method. This includes conditions caused by biologic, chemical, and pharmaceutical agents
Neurologic disorders caused by exposure to toxic substances through ingestion, injection, cutaneous application, or other method. This includes conditions caused by biologic, chemical, and pharmaceutical agents
Neurologic disorders caused by exposure to toxic substances through ingestion, injection, cutaneous application, or other method. This includes conditions caused by biologic, chemical, and pharmaceutical agents
Neurologic disorders caused by exposure to toxic substances through ingestion, injection, cutaneous application, or other method. This includes conditions caused by biologic, chemical, and pharmaceutical agents
1
Neurotoxinen. : Mineral and metal neurotoxicology / edited by Masayuki Yasui [and others]
Toxic substances from microorganisms, plants or animals that interfere with the functions of the nervous system. Most venoms contain neurotoxic substances. Myotoxins are included in this concept
Neurotoxins -- therapeutic use : Cosmetic injection techniques : a text and video guide to neurotoxins and fillers / Theda C. Kontis, Victor G. Lacombe, Sarah E. Faris
2019
1
Neurotoxins -- toxicity : Methylmercury and neurotoxicity / Sandra Ceccatelli, Michael Aschner, editors
Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function
1
Neurotransmitter. : Neurobiology of DOPA as a neurotransmitter / [editors] Yoshimi Misu, Yoshio Goshima
